HADA (Synonyms: HCC-Amino-D-alanine hydrochloride) |
|
رقم الكتالوجGC50533
|
هذا (HCC-Amino-D-alanine hydrochloride) هو حمض أميني D-فلورسنتي أزرق اللون (Λem~450 نانومتر).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2253733-10-5
Sample solution is provided at 25 µL, 10mM.
HADA (HCC-amino-D-alanine hydrochloride) is a blue fluorescent D-amino acid (FDAA), which is suitable for peptides in living bacteria, which stimulates/emitted λ ~ 405/460 nm. Without affecting the growth rate, FDAA can effectively conduct an external peripheral and diaphragm marking of different bacterial cell groups to display mitochondrial permeability[1-2].
The D-FDAA probe can marked PG growth sites in a series of different bacteria. FDAA is mixed with PG through DD transpeptidase (penicillin binding protein, PBP) or LD transpeptidase (LDT) (if existence). FDAA can be marked with species in a fast growth process in only 30 seconds, such as E. coli. HADA is capable of reproducible, stable labeling of PG for most bacterial species, usually without extensive optimization[1-3].
References:
[1] Botella H, Yang G, Ouerfelli O, et al. Distinct spatiotemporal dynamics of peptidoglycan synthesis between Mycobacterium smegmatis and Mycobacterium tuberculosis[J]. MBio, 2017, 8(5): 10.1128/mbio. 01183-17.
[2] Peters K, Pazos M, Edoo Z, Hugonnet JE, Martorana AM, Polissi A, VanNieuwenhze MS, Arthur M, Vollmer W. Copper inhibits peptidoglycan LD-transpeptidases suppressing β-lactam resistance due to bypass of penicillin-binding proteins. Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10786-10791.
[3] Mendes S S, Marques J, Mesterházy E, et al. Synergetic antimicrobial activity and mechanism of clotrimazole-linked CO-releasing molecules[J]. ACS bio & med Chem Au, 2022, 2(4): 419-436.
This protocol only provides a guideline, and should be modified according to your specific needs.
1. Prepare the following solutions in advance: TSB (or LB), TSB (LB) agar plate, 50 mM HADA stock solution(in DMSO), 10× and 1× sodium citrate buffer, 1×PBS and 3% paraformaldehyde.
2. Thaw the glycerol stock of the bacterial strain on ice. Use an inoculating loop to streak the strain onto TSB agar plates and incubate overnight at 37 °C. Then inoculate 25 ml of TSB (or LB) medium with a single bacterial colony and incubate overnight at 37 °C.
3. Dilute the overnight culture to an OD578 of 0.1 in TSB (or LB) media and grow at 37 °C until it reaches an exponential OD578 of 0.4.
4. The cells were diluted to OD578 0.1 using TSB (or LB) preheated at 37°C, and 500μl was placed in sterile 1.5 ml micro-tube.
5. Add 2.5 µl of 50 mM HADA stock solution to the sample to a final concentration of 250 μM and incubate at 37 °C with shaking for 30 minutes.
6. Add one-tenth the final volume of pre-chilled 10×sodium citrate buffer (50 µl, pH 2.25) to the growing culture.
7. Centrifuge the sample at 16,200 xg for 2 min at 4 °C. The supernatant was discarded and the precipitate was resuspended using 1.5 ml of ice-cold 1× sodium citrate buffer (pH 3.0).
8. Centrifuge the sample at 16,200 xg for 2 minutes at 4 °C. The supernatant was discarded and the precipitate was resuspended using 1.5 ml of ice-cold 1 x PBS (pH 7.4), then the sample was centrifuged again. Repeat the wash step once with ice-cold 1×PBS (pH 7.4). Carefully discard the supernatant without touching the cell precipitate.
9. Fix the cells by resuspending the cell pellet in 12.5 µl 1×PBS and 12.5 μl 3% paraformaldehyde. Mix well with a pipette and store on ice or at 4 °C until microscopic analysis.
10. Microscopic analysis: 3 μl of fixed cells were pipetted into the well of a prepared microscope agarose slide, and a square cover slip was carefully placed on top, pressing gently. Labeled cells were analyzed using an Eclipse Ti microscope (Plan Fluor×100/1.30 Oil Ph3 DLL objective) equipped with a Cool SNAP HQ2CCD camera, using phase contrast and DAPI channels (excitation wavelength 350/50 nm, emission wavelength 460/50 nm). An exposure time of 100 ms was used for phase contrast analysis, and an exposure time of 1 s was used for fluorescence image analysis.
Notes:
1. Before use, filter with a 0.22 μm filter membrane and pre-cool 10× and 1× sodium citrate buffer, 1× PBS and 3% paraformaldehyde solution on ice.
2. HADA is barely fluorescent at acidic pH or in unbuffered water, and cells imaged at pH above 7.0 show maximum brightness of HADA labeling. The last two wash steps are critical.
3. Microscopic analysis of labeled cells should be performed immediately after fixation.
4. With this protocol, all analyzed cells were fully labeled, showing stronger signals at the septa of contracting cells. Addition of 10×sodium citrate buffer to growing cells, initial washes with 1× sodium citrate buffer, pH 3.0, and rapid processing of samples on ice can improve the removal of unincorporated HADA and lead to reduced background fluorescence signals and improved signal detection.
References:
[1] Peters K, Pazos M, VanNieuwenhze M S, et al. Optimized Protocol for the Incorporation of FDAA (HADA Labeling) for in situ Labeling of Peptidoglycan[J]. Bio-protocol, 2019, 9(15): e3316-e3316.
| Cas No. | 2253733-10-5 | SDF | |
| المرادفات | HCC-Amino-D-alanine hydrochloride | ||
| Canonical SMILES | N[C@@H](C(O)=O)CNC(C1=CC(C=CC(O)=C2)=C2OC1=O)=O.Cl | ||
| Formula | C13H12N2O6.HCl | M.Wt | 328.71 |
| الذوبان | DMSO : 125 mg/mL (380.27 mM; Need ultrasonic) | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.0422 mL | 15.211 mL | 30.422 mL |
| 5 mM | 608.4 μL | 3.0422 mL | 6.0844 mL |
| 10 mM | 304.2 μL | 1.5211 mL | 3.0422 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 3 reference(s) in Google Scholar.)















